{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-26-000079","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2026-09-16T12:00:53+00:00","discovered_at":"2026-09-16T12:05:00.282780+00:00","generated_at":"2026-09-16T12:05:07.265874+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Myriad appoints Vishal Sikri EVP Commercial; CCO Brian Donnelly departs","bullets":["Brian Donnelly steps down as Chief Commercial Officer effective Sept 16, 2026; remains non-executive through Sept 21, 2026 for transition.","Vishal Sikri promoted from SVP Product to EVP Commercial effective Sept 16, 2026.","Sikri brings molecular diagnostics/oncology expertise and prior commercial leadership roles.","Company reaffirms full-year 2026 financial guidance from July 30, 2026 earnings call."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-26-000079","json":"https://secwatch.observer/filing/0000899923-26-000079.json","markdown":"https://secwatch.observer/filing/0000899923-26-000079.md","text":"https://secwatch.observer/filing/0000899923-26-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000079/0000899923-26-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000079/mygn-20260915.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T12:05:07.265874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}